The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen

We assessed whether the immunogenicity of the two-dose Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen with a 56-day interval between doses was affected by exposure to malaria before dose 1 vaccination and by clinical episodes of malaria in the period immediately after dose 1 and after dose 2 vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Manno, Daniela, Patterson, Catriona, Drammeh, Abdoulie, Tetteh, Kevin, Kroma, Mattu Tehtor, Otieno, Godfrey Tuda, Lawal, Bolarinde Joseph, Soremekun, Seyi, Ayieko, Philip, Gaddah, Auguste, Kamara, Abu Bakarr, Baiden, Frank, Afolabi, Muhammed Olanrewaju, Tindanbil, Daniel, Owusu-Kyei, Kwabena, Ishola, David, Deen, Gibrilla Fadlu, Keshinro, Babajide, Njie, Yusupha, Samai, Mohamed, Lowe, Brett, Robinson, Cynthia, Leigh, Bailah, Drakeley, Chris, Greenwood, Brian, Watson-Jones, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459393/
https://www.ncbi.nlm.nih.gov/pubmed/37631885
http://dx.doi.org/10.3390/vaccines11081317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459393/
https://www.ncbi.nlm.nih.gov/pubmed/37631885
http://dx.doi.org/10.3390/vaccines11081317

Ejemplares similares